Literature DB >> 11206190

Gastrointestinal transit of dosage forms in the pig.

S S Davis1, L Illum, M Hinchcliffe.   

Abstract

The gastrointestinal transit of liquid, pellet and tablet formulations was measured under fasted conditions in the domestic pig (n = 4) using the technique of gamma scintigraphy. The mean times for 50% gastric emptying for liquid and pellet systems were 1.4 and 2.2 h, respectively; tablets emptied between 1.5 and 6.0 h. Total transit times were in the order of 50 h. These data conform well to published values for the transit of liquid and solid food materials in the pig. The times are much shorter than those previously published for the transit of solid dosage forms in the pig. We conclude that the domestic pig would be a good model to study the gastrointestinal transit of pharmaceutical formulations and the absorption of drug compounds.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11206190     DOI: 10.1211/0022357011775163

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  18 in total

1.  Microencapsulation of bacteriophage felix O1 into chitosan-alginate microspheres for oral delivery.

Authors:  Yongsheng Ma; Jennifer C Pacan; Qi Wang; Yongping Xu; Xiaoqing Huang; Anton Korenevsky; Parviz M Sabour
Journal:  Appl Environ Microbiol       Date:  2008-05-30       Impact factor: 4.792

2.  Relative bioavailability of chlorothiazide from mucoadhesive compacts in pigs.

Authors:  Karunakar Neelam; Ravichandran Mahalingam; Raj Birudaraj; Tom Alfredson; Pratap Anne; Xiaoling Li; Bhaskara R Jasti
Journal:  AAPS PharmSciTech       Date:  2009-11-10       Impact factor: 3.246

Review 3.  A physiologically based pharmacokinetic model of the minipig: data compilation and model implementation.

Authors:  Claudia Suenderhauf; Neil Parrott
Journal:  Pharm Res       Date:  2012-11-21       Impact factor: 4.200

4.  In vitro lipolysis data does not adequately predict the in vivo performance of lipid-based drug delivery systems containing fenofibrate.

Authors:  Nicky Thomas; Katharina Richter; Thomas B Pedersen; René Holm; Anette Müllertz; Thomas Rades
Journal:  AAPS J       Date:  2014-04-02       Impact factor: 4.009

5.  Oral bioavailability in pigs of a miconazole/hydroxypropyl-gamma-cyclodextrin/L-tartaric acid inclusion complex produced by supercritical carbon dioxide processing.

Authors:  Valéry Barillaro; Brigitte Evrard; Luc Delattre; Géraldine Piell
Journal:  AAPS J       Date:  2005-08-18       Impact factor: 4.009

6.  Biocoating-A Critical Step Governing the Oral Delivery of Polymeric Nanoparticles.

Authors:  Aharon Azagury; Cameron Baptista; Kosta Milovanovic; Hyeseon Shin; Peter Morello; James Perez-Rogers; Victoria Goldenshtein; Travis Nguyen; Arianna Markel; Soham Rege; Stephanie Hojsak; Alexander Perl; Carder Jones; Megan Fife; Stacia Furtado; Edith Mathiowitz
Journal:  Small       Date:  2022-05-23       Impact factor: 15.153

7.  Accelerometer-Based Assessment of Intestinal Peristalsis: Toward Miniaturized Low-Power Solutions for Intestinal Implants.

Authors:  Nora Vanessa de Camp; Axel Heimann; Oliver Kempski; Juergen Bergeler
Journal:  IEEE J Transl Eng Health Med       Date:  2018-09-20       Impact factor: 3.316

8.  Application of a Physiologically Based Pharmacokinetic Model to Develop a Veterinary Amorphous Enrofloxacin Solid Dispersion.

Authors:  Kaixiang Zhou; Meixia Huo; Wenjin Ma; Kun Mi; Xiangyue Xu; Samah Attia Algharib; Shuyu Xie; Lingli Huang
Journal:  Pharmaceutics       Date:  2021-04-22       Impact factor: 6.321

9.  Ex Vivo and In Vivo Characterization of Interpolymeric Blend/Nanoenabled Gastroretentive Levodopa Delivery Systems.

Authors:  Ndidi C Ngwuluka; Yahya E Choonara; Girish Modi; Lisa C du Toit; Pradeep Kumar; Leith Meyer; Tracy Snyman; Viness Pillay
Journal:  Parkinsons Dis       Date:  2017-04-26

10.  Penetration of fosfomycin into IPEC-J2 cells in the presence or absence of deoxynivalenol.

Authors:  Guadalupe Martínez; Denisa S Pérez; Alejandro L Soraci; María O Tapia
Journal:  PLoS One       Date:  2013-09-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.